PerZeption

We are a vision diagnostic startup in Boston.
#medicaldevices #medtech #visiondiagnostic #optometry #ophthalmology

[PerZeption @PerZeptionInc]

We got lots of attention during this year's ARVO2026, including eyeoneyecare: https://t.co/7t1WugyBxe

[PerZeption @PerZeptionInc]

Read the full paper here: https://t.co/HdnWTohnVX

[PerZeption @PerZeptionInc]

Just in time for the holidays —exciting news!
Our latest validation study is out in the Journal of Translational Medicine:
"Novel color vision assessment tool: AIM color detection and discrimination" by Jingyi He, @JanSkerswetat , & Peter Bex.

[PerZeption @PerZeptionInc]

Key findings highlight AIM's comparable accuracy to anomaloscopes, with high repeatability and potential for clinical and research applications.

[PerZeption @PerZeptionInc]

Dr. @JanSkerswetat joined the Bench2Bedside event organized by @UCIrvine's Center for Translational Vision Research, presenting @PerZeptionInc 's test validation results. Exciting talks on advanced assessments with researchers & ophthalmologists in the drug development space!

[PerZeption @PerZeptionInc]

A paper on visual motion & form coherence processing in cerebral visual impairment using our FInD technology, published in Developmental Medicine & Child Neurology, is among the top 10 most-cited papers of 2023 ! https://t.co/hQUt0cT90V
#visionresearch #CVI

[PerZeption @PerZeptionInc]

A paper on visual motion & form coherence processing in cerebral visual impairment using our FInD technology, published in Developmental Medicine & Child Neurology, is among the top 10 most-cited papers of 2023 ! https://t.co/hQUt0cT90V #visionresearch #CVI

[PerZeption @PerZeptionInc]

More research using PerZeption Technology to be presented at #ARVO2025 @ARVOinfo

May 5, 3:00-4:45 PM (MT)
Poster Hall, Session 250, A0373
Psychometric outcomes in amblyopic kids using AIM on tablets.
#VisionResearch #Amblyopia

[PerZeption @PerZeptionInc]

More research using PerZeption Technology to be presented at #ARVO2025 May 5, 8:30-10:15 AM, Poster Hall, Session 217,  A0244: Adaptive Visual Acuity Testing in Albinism
Study shows repeatable AIM Acuity tech detects vision loss in PwA, with higher blur tolerance.
@ARVOinfo

[PerZeption @PerZeptionInc]

Join us at the ARVO Annual Meeting, the premier gathering for eye and vision scientists globally, held May 4-8, 2025, in Salt Lake City, Utah. We will present 3 different projects, stay tuned for more information. #ARVO2025 #VisionScience @ARVOinfo
https://t.co/sqdl2xPM4k

[PerZeption @PerZeptionInc]

Join us at the ARVO Annual Meeting, the premier gathering for eye and vision scientists globally, held May 4-8, 2025, in Salt Lake City, Utah. We will present 3 different projects, stay tuned for more information. #ARVO2025 #VisionScience @ARVOinfo
https://t.co/sqdl2xPM4k

[PerZeption @PerZeptionInc]

Important Team Update: Orion Wilmerding, software architect and previous founder in the medical device sector, has joined the PerZeption team as Chief Technology Officer. #visionscience #medicaldevice #Ophthalmology https://t.co/aMg1bKk2nK

[PerZeption @PerZeptionInc]

Our PerZeption app’s tablet-based CVD screening got a spotlight in JOSAA! AIM & FInD methods showed strong results for efficient, accurate testing. Read more about how we’re advancing vision diagnostics in our latest blog https://t.co/s7twovZ8ZQ #VisionScience #ColorVision

[PerZeption @PerZeptionInc]

Our PerZeption app’s tablet-based CVD screening got a spotlight in JOSAA! AIM & FInD methods showed strong results for efficient, accurate testing. Read more about how we’re advancing vision diagnostics in our latest blog https://t.co/s7twovZ8ZQ #VisionScience #ColorVision

[PerZeption @PerZeptionInc]

1 in 4 people—2.2 billion—face vision loss. Our mission is to prevent this with cutting-edge vision technology for clinicians. We’ve validated our app, scaled our tech, expanded our team, and redesigned our webpage. Our new app is ready—more updates soon. https://t.co/s7twovZ8ZQ

[PerZeption @PerZeptionInc]

New validation of FInD technology in people with and without color vision deficit.👇

[Jan Skerswetat @JanSkerswetat]

🚨New Paper out🚨

We introduce the new self-administered, adaptive color vision detection and discrimination task using the FInD platform tech. /🧵

@JY10251 @BexLab
https://t.co/XjqxrLvswJ

[Jan Skerswetat @JanSkerswetat]

🚨New Paper out🚨

We introduce the new self-administered, adaptive color vision detection and discrimination task using the FInD platform tech. /🧵

@JY10251 @BexLab
https://t.co/XjqxrLvswJ

[Jan Skerswetat @JanSkerswetat]

🚨New paper🚨Alongside Prof Merabet & colleagues from @harvardmed we used the new, generalizable FInD method to test motion and form processing in people w/wo Cerebral Visual Impairment. #visionscience
https://t.co/qWyk5jpBJ3